Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Neuropharmacology of addiction and how it informs treatment.

Lingford-Hughes A, Watson B, Kalk N, Reid A.

Br Med Bull. 2010;96:93-110. doi: 10.1093/bmb/ldq032. Epub 2010 Nov 2. Review.

PMID:
21044987
2.

Neuropharmacology of addiction--setting the scene.

Lawrence AJ, Beart PM, Kalivas PW.

Br J Pharmacol. 2008 May;154(2):259-60. doi: 10.1038/bjp.2008.131. Epub 2008 Apr 14.

3.

Drug dependence: neuropharmacology and management.

Deslandes PN, Pache DM, Sewell RD.

J Pharm Pharmacol. 2002 Jul;54(7):885-95. Review.

PMID:
12162706
4.

Addiction and withdrawal--current views.

Melichar JK, Daglish MR, Nutt DJ.

Curr Opin Pharmacol. 2001 Feb;1(1):84-90. Review.

PMID:
11712541
5.

From neurobiology to treatment: progress against addiction.

Nestler EJ.

Nat Neurosci. 2002 Nov;5 Suppl:1076-9. Review.

PMID:
12403990
6.
7.

[Principles of the pharmacological treatment of drug addiction].

Saadan M, Scuvée-Moreau J, Seutin V.

Rev Med Liege. 2013 May-Jun;68(5-6):245-51. French.

8.

Neurobiology of addiction. Toward the development of new therapies.

Koob GF.

Ann N Y Acad Sci. 2000;909:170-85. Review.

PMID:
10911930
9.

Neurobiology of addiction and implications for treatment.

Lingford-Hughes A, Nutt D.

Br J Psychiatry. 2003 Feb;182:97-100. Review. No abstract available.

10.

Future directions in substance dependence research.

Nutt D, Lingford-Hughes A, Daglish M.

J Neural Transm Suppl. 2003;(64):95-103. Review.

PMID:
12830931
11.

Role of oxytocin in the neuroadaptation to drugs of abuse.

Sarnyai Z, Kovács GL.

Psychoneuroendocrinology. 1994;19(1):85-117. Review.

PMID:
9210215
12.

A review of addiction.

Clay SW, Allen J, Parran T.

Postgrad Med. 2008 Jul 31;120(2):E01-7. doi: 10.3810/pgm.2008.07.1802. Review.

PMID:
18654058
13.

Chronic neuropharmacology of cocaine: progress in pharmacotherapy.

Gawin FH.

J Clin Psychiatry. 1988 Feb;49 Suppl:11-6. Review.

PMID:
3276669
14.

Cerebral monoamine neurotransmitters in opioid withdrawal and dependence.

Ahtee L, Attila LM.

Med Biol. 1987;65(2-3):113-9. Review.

PMID:
2888928
15.

Could a common biochemical mechanism underlie addictions?

Betz C, Mihalic D, Pinto ME, Raffa RB.

J Clin Pharm Ther. 2000 Feb;25(1):11-20. Review.

PMID:
10771460
16.

[Neurobiology and psychology of addictions].

Beine A, de Timary P, Hermans E.

J Pharm Belg. 2006;61(1):15-25. Review. French.

PMID:
16669343
17.

Neuropharmacology of cocaine and ethanol dependence.

Koob GF, Weiss F.

Recent Dev Alcohol. 1992;10:201-33. Review.

PMID:
1350359
18.

Drug addiction and brain targets: from preclinical research to pharmacotherapy.

Rahman S.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):391-2. No abstract available.

PMID:
19128198
19.

Medications development at the National Institute on Drug Abuse: focus on cocaine.

Johnson DN, Vocci FJ.

NIDA Res Monogr. 1993;135:57-70. Review.

PMID:
8289904
20.

Novel pharmacological approaches to drug abuse treatment.

Edens E, Massa A, Petrakis I.

Curr Top Behav Neurosci. 2010;3:343-86. doi: 10.1007/7854_2009_29. Review.

PMID:
21161760

Supplemental Content

Support Center